Vés al contingut

Catàleg de models animals del Vall d'Hebron Barcelona Hospital Campus

Utilitza el cercador per trobar els models que necessites per a la teva investigació.

Reference Name Animal specie Strain Thematic area Specific pathology Description
AT015 Dry macular degeneration murine model Mice (Mus musculus) DKO rd8 (Ccl2-/-/Cx3cr1-/-/Crb1rd8/rd8) Diseases of the sense organs (skin, eyes and ears) Age-related macular degeneration
The DKO rd8 is obtained by crossing the C57BL/6NJ strain (homozygous for the Crb1rd8 mutation, the B6.129S4-*Ccl2tm1Rol*/J strain (homozygous for the Ccl2tm1Rol (Ccl2-/-) mutation), and the B6. 129P-*Cx3cr1tm1Litt*/J strain (homozygous for the Cx3cr1tm1Litt (Cx3cr1-/-) mutation). Availability: Cryopreserved
AT131 Drug-induced pathological Cardiac Remodelling mouse model Mice (Mus musculus) C57BL/6J Cardiovascular diseases Heart failure
Model generated by Implantation of subcutaneous angiotensin II release pump
AT130 Drug-induced pathological Cardiac Remodelling mouse model Mice (Mus musculus) C57BL/6J Cardiovascular diseases Heart failure
Model generated by Implantation of subcutaneous isoproterenol release pump
AT014 DIO (diet-induced obesity) Mice (Mus musculus) C567BL/6 Endocrinology Disorders of body’s energy balance; Obesity; Type 2 diabetes
This model exhibits servere obesity and altered glucose homeostasis (glucose intolerance and insulin resistance) after being fed with a high fat diet (45% Kcal from fat) or very high fat diet (60 % kcal from fat).
AT013 Diabetic rats by injection with streptozotocin (STZ) Rat (Rattus norvegicus) Long-Evans
Sprague-Dawley
Type 2 Diabetes; Type 1 Diabetes Diabetic Macular Edema
The low-dose streptozotocin model has been widely used for years in numerous publications with excellent results. The main advantage of drug delivery-based models is that the degree of β-cell disruption can be regulated according to the dose of toxin administered. This diabetic rat constitutes a good model because it generates vascular dysfunction and retinal neurodegeneration similar to human pathogenesis and allows obtaining sufficient amounts of retinal RNA or protein for experimental procedures. 1 dose of 65 mg/kg of STZ solution intraperitoneally. A week after stabilization, weight and blood glucose are measured. If the injected rats have a blood glucose level of > 250 mg/dl, they are considered diabetic.
AT012 Dexamethasone-induced Glaucoma Mice (Mus musculus) C57BL/6 Diseases of the sense organs (skin, eyes and ears) Glaucoma
Dexamethasone induces intraocular hypertension and a degeneration of the optic nerve
AT129 Cyclosporine (CsA)-induced Renal Toxicity model Mice (Mus musculus) C57BL/6 Nephrology Renal toxicity
Model generated by intramuscular injection of cyclosporine (CsA)
AT011 Cx43-deficiency in mice induced by 4-hydroxytamoxifen intraperitoneal administration Mice (Mus musculus) Hybrid strain C57BL6J y OlaHsd: Cx43Cre-ER(T)/fl Cardiovascular diseases Cardiac deletion of Cx43: arrhythmias and sudden death (50% after 14 days of induction)
Ablation of Cx43 expression is achieved by 4-hydroxytamoxifen (4-OHT) treatment in adult mice intraperitoneally injected once a day, for 5 consecutive days, with 3 mg of 4-OHT.
AT009 Chronic Liver Disease induced by intraperitoneal injection of thioacetamide (TAA) Rat (Rattus norvegicus) Sprague-Dawley OFA Liver Diseases Hepatic cirrhosis
Rats receive the first week a dose of 250mg/Kg IP of TAA twice a week, the following 7 weeks they receive a dose of 200mg/Kg IP twice a week, being a total of 8 weeks and 16 injections After 8 weeks of treatment at a dose of 250-200mg/kg, twice a week, all animals will develop histological features of cirrhosis
AT008 Chronic Liver Disease induced by inhalation of carbon tetrachloride (CCl4) Rat (Rattus norvegicus) Wistar Han Liver Diseases Hepatic cirrhosis
With the administration of CCl4 we produce an acute hepatitis, and with its continued administration we generate a chronic liver injury that leads to the development of cirrhosis. To speed up the model, phenobarbital is administered to water (0.3 g/L) one week before starting the hepatotoxic exposure and until the end of the experiment We will consider that the animal has developed cirrhosis with portal hypertension after 12 weeks of inhalation.

Sol·licitud de models animals

Aquest catàleg s'actualitza anualment. Per informació addicional i/o sol·licitar models animals, pots posar-te en contacte amb nosaltres a catalogo.animales@vhir.org.

També podeu cercar models animals a la Plataforma ISCIII de Biomodels i Biobancs.